Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

Choi, Sung R., Howell, Owain W., Carassiti, Daniele, Magliozzi, Roberta, Gveric, Djordje, Muraro, Paolo A., Nicholas, Richard, Roncaroli, Federico +1 more·2012·Brain
DOI 10.1093/brain/aws189

Cited by (385)

Items 201–300 of 385

  1. Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
    Edgar Carnero Contentti, Jorge Daniel Correale · 2022 · Drug Design Development and Therapy
  2. Imaging cortical lesions in multiple sclerosis
    Caterina Mainero, Constantina A. Treaba, Elena Barbuti · 2023 · Current Opinion in Neurology
  3. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
    María Cristina Ortega, Rafael Lebrón‐Galán, Isabel Machín-Díaz, Michelle Naughton, Inmaculada Pérez-Molina, Jennifer García-Arocha, José Manuel García‐Domínguez, Haydee Goicoechea-Briceño, Virginia Vila‐del Sol, Víctor Quintanero-Casero et al. · 2023 · Acta Neuropathologica
  4. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: A voxel-based analysis study
    Shahrukh Mallik, Nils Muhlert, Rebecca S. Samson, Varun Sethi, Claudia A. M. Gandini Wheeler‐Kingshott, David H. Miller, Declan Chard · 2014 · Multiple Sclerosis Journal
  5. Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis
    Bert A. ‘t Hart · 2019 · Primate Biology
  6. Leptomeningeal Enhancement on 3D‐FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice
    David S. Titelbaum, Renate Engisch, Eric D. Schwartz, Salvatore Q. Napoli, Jacob A. Sloane, Soleil Samaan, Joshua B. Katz, Ellen S. Lathi · 2020 · Journal of Neuroimaging
  7. Meningeal immunity and neurological diseases: new approaches, new insights
    Yun Su, Huimin Zheng, Changhe Shi, Xinwei Li, Shuyu Zhang, Guangyu Guo, Wen-Kai Yu, Shuo Zhang, Zhengwei Hu, Jing Yang et al. · 2023 · Journal of Neuroinflammation
  8. Re-programming immunosurveillance in persistent non-infectious ocular inflammation
    Simon J. Epps, Joanne Boldison, Madeleine L. Stimpson, Tarnjit K. Khera, Philippa J. P. Lait, David A. Copland, Andrew D. Dick, Lindsay B. Nicholson · 2018 · Progress in Retinal and Eye Research
  9. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis
    Jacob Talbot, Helene Højsgaard Chow, Mie Reith Mahler, Sophie Buhelt, Rikke Holm Hansen, Henrik Lundell, Tua Vinther‐Jensen, Marie N.N. Hellem, Jørgen Erik Nielsen, Hartwig Roman Siebner et al. · 2022 · Multiple Sclerosis and Related Disorders
  10. Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives
    Qingqing Zhou, Rui Jia, Jingxia Dang · 2022 · Neurology Research International
  11. BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
    Kanak Gupta, Ajay Kesharwani, Steven Rua, Saumitra Sen Singh, Catherine Siu, Larissa Jank, Matthew D. Smith, Peter A. Calabresi, Pavan Bhargava · 2023 · Journal of Neuroinflammation
  12. Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques
    M. Petracca, M. Margoni, Giulia Bommarito, M. Inglese · 2018 · Neurological Therapeutics
  13. Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome
    Ismail Koubiyr, Mathilde Deloire, Pierrick Coupé, Cécile Dulau, Pierre Besson, Amandine Moroso, Vincent Planche, Thomas Tourdias, Bruno Brochet, Aurélie Ruet · 2018 · Frontiers in Neurology
  14. Relevance of choroid plexus volumes in multiple sclerosis
    Britta Krieger, Barbara Bellenberg, Anna Katharina Roenneke, Ruth Schneider, Theodoros Ladopoulos, Zainab Abdul Kareem Abbas, Rebekka Rust, Tanja Schmitz‐Hübsch, Claudia Chien, Ralf Gold et al. · 2025 · Fluids and Barriers of the CNS
  15. Follicle on the Roof: Tertiary Lymphoid Structures in Central Nervous System Autoimmunity
    Michelle Zuo, Angela A. Wang, Jennifer L. Gommerman · 2025 · Immunological Reviews
  16. Tertiary lymphoid structures in the central nervous system
    Chao‐Chun Yang, Yuxiang Cai, Ze-Fen Wang, Su-Fang Tian, Zhiqiang Li · 2024 · Trends in Molecular Medicine
  17. Continuous Immune-Modulatory Effects of Human Olig2+ Precursor Cells Attenuating a Chronic-Active Model of Multiple Sclerosis
    Yossi Nishri, David W. Hampton, Etti Ben-Shushan, Nina Fainstein, Dario Magnani, Michal Aharonowiz, Benjamin E. Reubinoff, Siddharthan Chandran, Tamir Ben‐Hur · 2019 · Molecular Neurobiology
  18. A simple procedure for the extraction of DNA from long-term formalin-preserved brain tissues for the detection of EBV by PCR
    Asma Hassani, Gulfaraz Khan · 2015 · Experimental and Molecular Pathology
  19. Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab
    James William L Brown, Ferrán Prados, Arman Eshaghi, Carole H. Sudre, Tom Button, Matteo Pardini, Rebecca S. Samson, Sebastien Ourselin A, Claudia A. M. Gandini Wheeler‐Kingshott, Joanne Jones et al. · 2019 · Multiple Sclerosis Journal
  20. Substantial subpial cortical demyelination in progressive multiple sclerosis: have we underestimated the extent of cortical pathology?
    Lauren Griffiths, Richard Reynolds, Rhian Evans, Ryan J. Bevan, Mark I. Rees, Djordje O. Gveric, James Neal, Owain W. Howell · 2020 · Neuroimmunology and Neuroinflammation
  21. Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis
    Tereza Gabelić, Barbara Barun, Ivan Adamec, Magdalena Krbot Skorić, Mario Habek · 2021 · Human Vaccines & Immunotherapeutics
  22. Intruders or protectors – the multifaceted role of B cells in CNS disorders
    James W Aspden, M. Murphy, Rommi Kashlan, Yue-Yue Xiong, M. Poznansky, R. F. Sîrbulescu · 2024 · Frontiers in Cellular Neuroscience
  23. Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis
    Simões-Abade, Madalena B. C., Patterer, Marlene, Nicaise, Alexandra M., Pluchino, Stefano · 2024 · Frontiers in Cellular Neuroscience
  24. Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis
    Petros Pousinis, Inês Ramos, M. Nicola Woodroofe, Laura M. Cole · 2020 · Metabolites
  25. Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets
    Xiaohong Ma, Rong Ma, Meng-Zhe Zhang, Baicheng Qian, Baoliang Wang, Wei-Jing Yang · 2023 · Pharmaceutics
  26. Relapsing–remitting and primary progressive MS have the same cause(s) – the neuropathologist’s view: 1
    Hans Lassmann · 2013 · Multiple Sclerosis Journal
  27. A Dual Role of Osteopontin in Modifying B Cell Responses
    Rittika Chunder, Verena Schropp, Manuel C. Marzin, Sandra Amor, Stefanie Küerten · 2023 · Biomedicines
  28. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS
    Matteo Pardini, Maria Petracca, Asaff Harel, Lazar Fleysher, Niels Oesingmann, Giulia Bommarito, Michelle T. Fabian, Declan Chard, FRED D. LUBLIN, Matilde Inglese · 2017 · NeuroImage Clinical
  29. Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis
    Molly E. Church, Guadalupe Ceja, Megan McGeehan, Miles C. Miller, Priscilla Farias, Melissa D. Sánchez, Gary P. Swain, Charles‐Antoine Assenmacher, Edward G. Stopa, Charles H. Vite et al. · 2021 · The Journal of Immunology
  30. Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse
    Nishri, Yossi, Fainstein, Nina, Goldfarb, Smadar, Hampton, David, Macrini, Caterina, Meinl, Edgar, Chandran, Siddharthan, Ben-Hur, Tamir · 2021 · Journal of Neuroimmunology
  31. New Ways of “Seeing” the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis
    Ethan I. Meltzer, Fiona Costello, Elliot M. Frohman, Teresa C. Frohman · 2018 · Journal of Neuro-Ophthalmology
  32. Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics
    Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, Elizaveta J. James, Mainthan Palendira, Simon H Hawke, Georges E. Grau · 2024 · Sclerosis
  33. Intrathecal immune reset in multiple sclerosis: Exploring a new concept
    Mickaël Bonnan · 2014 · Medical Hypotheses
  34. The spectrum of spinal cord lesions in a primate model of multiple sclerosis
    Jennifer Lefeuvre, Joseph R Guy, Nicholas J. Luciano, Seung-Kwon Ha, Emily C. Leibovitch, Mathieu David Santin, Afonso C. Silva, Steven Jacobson, Stéphane Lehéricy, Daniel S. Reich et al. · 2019 · Multiple Sclerosis Journal
  35. Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous System
    Michael D. Kornberg, Peter A. Calabresi · 2024 · Cold Spring Harbor Perspectives in Biology
  36. Cortical Lesions as an Early Hallmark of Multiple Sclerosis: Visualization by 7 T MRI
    Pierre Durozard, Adil Maarouf, Wafaa Zaaraoui, Jan‐Patrick Stellmann, Clémence Boutière, Audrey Rico, Sarah Demortière, Maxime Guye, Arnaud Le Troter, Hugo Dary et al. · 2024 · Investigative Radiology
  37. Microglia and Multiple Sclerosis
    Brady P. Hammond, Sharmistha P. Panda, Deepak Kumar Kaushik, Jason R. Plemel · 2024 · Advances in neurobiology
  38. Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond
    Océane Perdaens, Vincent Van Pesch · 2024 · International Journal of Molecular Sciences
  39. Primary progressive multiple sclerosis—why we are failing
    Benjamin M. Segal, Olaf Stüve · 2016 · The Lancet
  40. Mechanisms of Neurodegeneration in Multiple Sclerosis
    Daria D. Eliseeva, Mariya N. Zakharova · 2022 · S S Korsakov Journal of Neurology and Psychiatry
  41. Single-Cell Profiling Indicates a Proinflammatory Role of Meningeal Ectopic Lymphoid Tissue in Experimental Autoimmune Encephalomyelitis
    Jolien Diddens, Gildas Lepennetier, Verena Friedrich, Monika Schmidt, Rosa Margareta Brand, Tanya Georgieva, Bernhard Hemmer, Klaus Lehmann‐Horn · 2023 · Neurology Neuroimmunology & Neuroinflammation
  42. Emerging drugs for primary progressive multiple sclerosis
    Ram Narayan, Thomas G. Forsthuber, Olaf Stüve · 2018 · Expert Opinion on Emerging Drugs
  43. Age-related changes in multiple sclerosis and experimental autoimmune encephalomyelitis
    Michelle Zuo, Valeria Ramaglia, Jennifer L. Gommerman · 2022 · Seminars in Immunology
  44. Profile of Polish patients with primary progressive multiple sclerosis
    Waldemar Brola, Piotr Sobolewski, Marek Žák, Stanisław Flaga, Małgorzata Fudala, Dominik Siutka, Katarzyna Kapica-Topczewska, Monika Chorąży, Alina Kułakowska, Adam Perenc et al. · 2019 · Multiple Sclerosis and Related Disorders
  45. An overview on disease modifying and symptomatic drug treatments for multiple sclerosis
    Gloria Dalla Costa, L. Leocani, M. Rodegher, L. Chiveri, A. Gradassi, G. Comi · 2024 · Expert Review of Clinical Pharmacology
  46. Multiple sclerosis: etiology in the context of neurovascular unit and immune system involvement and advancements with in vitro blood–brain barrier models
    Aya A. El-Taibany, Parichehr Heydarian, Daniel A. Porada, Michael C. Seeds, Anthony Atala · 2025 · Frontiers in Immunology
  47. Cytotoxic profile of CD3+CD20+ T cells in progressive multiple sclerosis
    Vinicius de Oliveira Boldrini, Raphael Patrício Silva Quintiliano, Lucas Scárdua Silva, Alfredo Damasceno, Leonilda Maria Barbosa dos Santos, Alessandro S. Farias · 2021 · Multiple Sclerosis and Related Disorders
  48. Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
    Aigli G. Vakrakou, Nikolaos Paschalidis, Eleftherios Pavlos, Christina C. Giannouli, Dimitris Karathanasis, Xristina Tsipota, Georgios Velonakis, Christine Stadelmann, Maria‐Eleftheria Evangelopoulos, Leonidas Stefanis et al. · 2023 · Frontiers in Immunology
  49. Can leptomeningeal enhancement be linked to multiple sclerosis?
    Frederik Barkhof, Daniel S. Reich · 2015 · Neurology
  50. Multiple Sclerosis
    Massimo Filippi, Maria Assunta Rocca · 2020 · Springer eBooks
  51. Towards Treating Multiple Sclerosis Progression
    Darius Häusler, Martin S. Weber · 2024 · Pharmaceuticals
  52. Identification of a novel role for matrix metalloproteinase-3 in the modulation of B cell responses in multiple sclerosis
    Rittika Chunder, Verena Schropp, Samir Jabari, Manuel C. Marzin, Sandra Amor, Stefanie Küerten · 2022 · Frontiers in Immunology
  53. Multiple sclerosis: new measures to monitor the disease
    Massimo Filippi, Maria Assunta Rocca · 2012 · The Lancet Neurology
  54. Spring cleaning: time to rethink imaging research lines in MS?
    Martina Absinta, Daniel S. Reich, Massimo Filippi · 2016 · Journal of Neurology
  55. Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target?
    Berenice Anabel Silva, Carina Cintia Ferrari · 2018 · Reviews in the Neurosciences
  56. Remyelination in Multiple Sclerosis: What do we know and Where are we Going?
    Anna Williams · 2015 · Neurodegenerative Disease Management
  57. Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis
    Niraj Mistry, Jeremy Charles Hobart, David J. Rog, Nils Muhlert, Joela Mathews, David Baker, Gavin Giovannoni · 2024 · Multiple Sclerosis and Related Disorders
  58. Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression
    Anat Achiron, Sapir Dreyer-Alster, Michael Gurevich, Shay Menascu, David Magalashvili, Mark Dolev, Yael Stern, Tomer Ziv‐Baran · 2021 · Multiple Sclerosis and Related Disorders
  59. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
    Cathérine Dekeyser, Matthias Hautekeete, Melissa Cambron, Vincent Van Pesch, Francesco Patti, Jens Kühle, Samia Joseph Khoury, Jeannette Lechner‐Scott, Oliver H.H. Gerlach, Alessandra Lugaresi et al. · 2024 · Journal of Neurology Neurosurgery & Psychiatry
  60. Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
    Krista D. DiSano, Michael R. Linzey, Nora C. Welsh, Joshua S. Meier, Andrew R. Pachner, Francesca Gilli · 2020 · Journal of Visualized Experiments
  61. Insights into the role of B cells in the cortical pathology of Multiple sclerosis: evidence from animal models and patients
    Berenice Anabel Silva, Esteban Alberto Miglietta, Carina Cintia Ferrari · 2021 · Multiple Sclerosis and Related Disorders
  62. Isoniazid in autoimmunity: a trigger for multiple sclerosis?
    Bardia Nourbakhsh, Olaf Stüve · 2014 · Therapeutic Advances in Neurological Disorders
  63. Dural ectopic lymphatic structures accumulate during aging and exhibit dysregulation in neurodegenerative diseases
    Amit Fruitman Davidi, Sophie D. Shirenova, Dolev Michaelovich, Giulio Benedetti, Hadar Shtrasberg, Irit Shoval, Hagit Hauschner, Gal Oz, Karin Vardy, Tamir Hirsh et al. · 2025 · Proceedings of the National Academy of Sciences
  64. Subcortical plaques and inflammation reflect cortical and meningeal pathologies in progressive multiple sclerosis
    Betül Okutan, Jette Lautrup Frederiksen, Gunnar Houen, Finn Thorup Sellebjerg, Cecilie Kyllesbech, Melinda Magyari, Manuela Paunovic, Per Soelberg Sørensen, Christina Jacobsen, Hans Lassmann et al. · 2024 · Brain Pathology
  65. Understanding the role of the blood brain barrier and peripheral inflammation on behavior and pathology on ongoing confined cortical lesions
    Berenice Anabel Silva, María Isabel Farías, Esteban Alberto Miglietta, María Celeste Leal, Juan Carlos Ávalos, Fernando Juan Pitossi, Carina Cintia Ferrari · 2021 · Multiple Sclerosis and Related Disorders
  66. Immunoglobulin directly enhances differentiation of oligodendrocyte-precursor cells and remyelination
    Yaguang Li, Daisuke Noto, Yasunobu Hoshino, Miho Mizuno, Soichiro Yoshikawa, Sachiko Miyake · 2023 · Scientific Reports
  67. Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
    Afsaneh Shirani, Olaf Stüve, Anne Haney Cross · 2023 · Neurologic Clinics
  68. Mechanisms of disease progression
    A. Wilkins · 2013 · Springer eBooks
  69. Sulcal and gyral crown cortical grey matter involvement in multiple sclerosis: A magnetisation transfer ratio study
    Rebecca S. Samson, Nils Muhlert, Varun Sethi, Claudia A. M. Gandini Wheeler‐Kingshott, María A. Ron, David H. Miller, Declan Chard · 2013 · Multiple Sclerosis and Related Disorders
  70. A Neuroprimer: Principles of Central Nervous System Immunity
    Gregory P. Owens · 2017 · Seminars in Pediatric Neurology
  71. Multiple Sclerosis
    Stephen L. Hauser, Jorge R. Oksenberg, Sergio E. Baranzini · 2014 · Elsevier eBooks
  72. Leptomeningeal enhancement in Susac’s syndrome and multiple sclerosis: Time to expect the unexpected?
    Jaume Sastre‐Garriga · 2016 · Multiple Sclerosis Journal
  73. The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
    De Masi, Roberto, Orlando, Stefania, De Donno, Antonella · 2021 · Pharmaceuticals
  74. The meninges as a neuroimmune interface: structure, barriers and roles in CNS disease
    Sarah Joost, Hannes Kaddatz, Elise Vankriekelsvenne, Lars‐Ove Brandenburg · 2026 · Fluids and Barriers of the CNS
  75. Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging
    Robert Zivadinov, Ferdinand Schweser, Dejan Jakimovski, Niels Bergsland, Michael G. Dwyer · 2024 · Neuroimaging Clinics of North America
  76. Discovery of grey matter lesion-related immune genes for diagnostic prediction in multiple sclerosis
    Peiyuan Zhao, Xihong Liu, Yunqian Wang, Xinyan Zhang, Han Wang, Xiaodan Du, Zhixin Du, Liping Yang, Junlin Hou · 2023 · PeerJ
  77. Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis
    Ranjan Dutta · 2013 · Multiple Sclerosis Journal
  78. Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies
    Jenny J. Feng, Daniel Ontaneda · 2017 · Degenerative Neurological and Neuromuscular Disease
  79. Cognitive Impairment in Multiple Sclerosis
    Aurélie Ruet · 2015 · Neuropsychiatric symptoms of neurological disease
  80. Pathology of Multiple Sclerosis
    Jordon Dunham, Kedar R. Mahajan · 2021 · Springer eBooks
  81. The Elusive B Cell Antigen in Multiple Sclerosis: Time to Rethink CNS B Cell Functions
    Florian Mailaender, Nicole Vasilenko, Maria P. Tieck, Sonja Schembecker, Markus Christian Kowarik · 2025 · International Journal of Molecular Sciences
  82. Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity
    Yodit Tesfagiorgis, Eden A. Kemal, Heather C. Craig, Kate A. Parham, Steven M. Kerfoot · 2023 · Journal of Neuroimmunology
  83. Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation
    Leonardo Marchi, Alice Mariottini, Vittorio Viti, Andrea Bianchi, Chiara Nozzoli, Anna Maria Repice, Riccardo Boncompagni, Andrea Ginestroni, Valentina Damato, Alessandro Barilaro et al. · 2024 · Frontiers in Neurology
  84. Tertiary Lymphoid Structures in Central Nervous System Disorders
    Alessandra Vaccaro, Beatriz de Alves Pereira, Tiarne van de Walle, Anna Dimberg · 2024 · Methods in molecular biology
  85. Organes lymphoïdes tertiaires méningés : des acteurs majeurs de l’auto-immunité intrathécale
    Mickaël Bonnan · 2014 · Revue Neurologique
  86. The only way to manage neurodegeneration in MS is to prevent it with effective anti-inflammatory therapy: Yes
    Nikos Evangelou · 2012 · Multiple Sclerosis Journal
  87. B cells in autoimmune diseases of the central nervous system
    Daisuke Noto, Sachiko Miyake · 2020 · Clinical and Experimental Neuroimmunology
  88. Molecular targeted therapy against B cells in multiple sclerosis
    Yusei Miyazaki, Masaaki Niino · 2014 · Clinical and Experimental Neuroimmunology
  89. Topological Aspects of the Blood–Brain and Blood–Cerebrospinal Fluid Barriers and Their Relevance in Inflammation
    Friederike Pfeiffer, Andreas F. Mack, Hartwig Wolburg · 2017 · Springer eBooks
  90. The Role of Toll-Like Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    B. Gran, M. Nyirenda, J. Crooks · 2013 · Springer eBooks
  91. The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era
    Thomas F. McNair Scott, Nicholas M. Bertha · 2020 · Journal of the Neurological Sciences
  92. The mechanism of disease progression by aging and age-related gut dysbiosis in multiple sclerosis
    Sudhir Kumar Yadav, Claire Chen, Suhayl S. Dhib-Jalbut, Kouichi Ito · 2025 · Neurobiology of Disease
  93. Subpial cortical demyelination in multiple sclerosis: A systematic review of frequency, pathology, and clinical diversity
    Masoud Etemadifar, Kamran Rezaei, Fatemeh Hojjatipour, Mehri Salari · 2025 · Multiple Sclerosis and Related Disorders
  94. Plasma cells in and around the central nervous system
    Alexander K. Merder, E. Ashley Moseman · 2026 · Frontiers in Immunology
  95. Single Cell Analysis of High-Parameter Histology Images Using Histoflow Cytometry
    Rajiv W. Jain, David A Elliott, Voon Wee Yong · 2023 · The Journal of Immunology
  96. Role of B cells in the pathogenesis of multiple sclerosis
    Hirofumi Ochi · 2021 · Clinical and Experimental Neuroimmunology
  97. Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis
    Tanya Georgieva, Jolien Diddens, Verena Friedrich, Gildas Lepennetier, Rosa Margareta Brand, Klaus Lehmann‐Horn · 2024 · Frontiers in Immunology
  98. Serum levels and genetic variation of IL-35 are associated with multiple sclerosis: a population-based case–control study
    Mina Eslami, Alireza Rafiei, Seyed Mohammad Baghbanian, Sadegh Fattahi, Zahra Yazdani, Reza Valadan, Mostafa Kardan · 2021 · Immunologic Research
  99. La part de l’inflammation dans la pathogénie de la sclérose en plaques
    Bruno Brochet · 2015 · Pratique Neurologique - FMC
  100. White Matter Disorders
    Brianne Magouirk Bettcher, Carolyn J. Bevan, Michael D. Geschwind · 2016 · Elsevier eBooks